Calcium Entry Blockers

Anderson K.E. (1985). Some extracardiac effects of Diltiazem and other calcium entry blockers. ACTA Pharmacology and Toxicology 57: Suppl II, 31–43.

Buhler F. Bolli P. Krowski W. Erne P. Hulthon U. , & Block L. (1984). Renin profiling to select antihypertensive baseline drugs. American Journal of Medicine, 77(suppl 22), 36A–42A.

Kirkendall W.M. (1986). Treatment of hypertension in the elderly. American Journal of Cardiology, 57, 63C–68C.

Laragh J.H. , & Sealey J.E. (1981). The reninaldosterone axis for blood pressure electrolyte homeostasis, and diagnosis of high blood pressure. In: Williams R.H. , ed. Textbook of Endocrinology, sixth ed. W.B. Saunders: Philadelphia, pp. 1064–1079.

Moser M. Lunn J. , & Materson B. (1985). Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension. American Journal of Cardiology, 56, 101H–104H.

Muller F.B. Bolli P. Erne P. Kowski W. , & Buhler F. (1986). Calcium antagonism — A new concept for treating essential hypertension. American Journal of Cardiology, 57, 50D–53D.

Piepho R.W. (1985). Individualization of calcium entry-blocker dosage for systemic hypertension. American Journal of Cardiology, 56, 105H–111H.

Schneck D. (1985). Calcium-entry blockers: A review of their basic clinical pharmacology and therapeutic applications. Pharmacology for Physicians, 19(5), 1–5.

The 1984 Report of the Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. (1984). Arch Intern Med 144, 1045–1057.